Should Genetic Testing Services be Regulated?

ConclusionIs it good for patients to know their genetic makeup and their possible health risks, or does it cause more problems than it solves? Does it create an open dialog between patients and HCPs, or does it clog up the system with unnecessary office visits and phone calls? Should the FDA regulate genetic testing services such as 23andMe, or call it an educational tool consumers can use or ignore at their discretion?Genetic testing services could be a boon to Pharma, because the more health information available to patients, the more likely they are to schedule visits with their doctor and address their health concerns. What’s your opinion? Tweet your thoughts using hashtag #DNAdiscussion.References:http://www.economist.com/news/business/21590941-regulator-brings-genetics-company-halt-and-fdahttp://www.bloomberg.com/news/2013-12-11/personal-gene-tests-face-stricter-oversight-after-23andme.htmlhttp://www.forbes.com/sites/quora/2013/12/11/what-do-doctors-think-about-23andme/https://www.23andme.com/ancestry-only-notice/
Source: ePharma Summit - Category: Medical Marketing and PR Tags: DNA Testing ePharma Summit Physicians and DNA Testing Source Type: blogs